Imidazole → HCID 44470537, compound
Reaction equation
CN(C=O)C.[N:6]([C:9]1[CH:18]=[CH:17][C:16]([OH:19])=[C:15]2[C:10]=1[CH:11]=[CH:12][C:13]([CH3:20])=[N:14]2)=[N+:7]=[N-:8].N1C=CN=C1.[Si:26](Cl)([C:39]([CH3:42])([CH3:41])[CH3:40])([C:33]1[CH:38]=[CH:37][CH:36]=[CH:35][CH:34]=1)[C:27]1[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=1>C(OCC)(=O)C>[N:6]([C:9]1[CH:18]=[CH:17][C:16]([O:19][Si:26]([C:39]([CH3:42])([CH3:41])[CH3:40])([C:33]2[CH:34]=[CH:35][CH:36]=[CH:37][CH:38]=2)[C:27]2[CH:32]=[CH:31][CH:30]=[CH:29][CH:28]=2)=[C:15]2[C:10]=1[CH:11]=[CH:12][C:13]([CH3:20])=[N:14]2)=[N+:7]=[N-:8]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
A 100-mL flask was successively loaded with dry DMF (10 mL), 13 (200 mg, 1 mmol), imidazole (68.08 mg, 1 mmol), and tert-butyldiphenylsilyl chloride (302 mg, 1.1 mmol). The solution was stirred at room temperature for 10 h, diluted with ethyl acetate (500 mL), washed with aqueous HCl (0.1 M, 50 mL), brine (100 mL), water (100 mL), dried over Na2SO4 and evaporated under reduced pressure to afford 8.41 g (96%) of protected product as a colorless oil (428 mg, 98%). 1H NMR (500 MHz, CDCl3) δ ppm: 1.19 (s, 9H), 2.33 (s, 3H), 6.98 (d, J=8.5 Hz, 1H), 7.06 (d, J=8.5 Hz, 1H), 7.10 (d, J=8.5 Hz, 1H), 7.38-7.26 (m, 6H), 7.81-7.79 (m, 4H), 8.11 (d, J=8.5 Hz, 1H). 13C NMR (125 MHz, CDCl3) δ ppm: 20.1, 24.3, 26.8, 113.5, 116.7, 120.6, 121.8, 127.3, 128.4, 129.2, 130.6, 134.3, 135.1, 140.9, 148.9, 157.9. HRMS (ESI): calc'd for C26H26N4OSi [M+H]+: 438.1876, found: 438.1879.
Workup
- washwashed with aqueous HCl (0.1 M, 50 mL), brine (100 mL), water (100 mL)
- dry with materialdried over Na2SO4
- customevaporated under reduced pressure
Sources & evidence
- ORD record
- ord-c05b54ed4a4f40db8c4914b505b4a8a7
- Source dataset
- uspto-grants-2013_04
- Patent number
- US08409820B2
Reaction notes
Loading…